Press Releases


263 Press Releases found

New Study Reveals Gut Microbes May Help Protect People Having a Bone Marrow Transplant

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

  • Sunday, December 2, 2018

New Leader Named for Memorial Sloan Kettering's Regional Care Network

Memorial Sloan Kettering Cancer Center has announced that Oren Cahlon, MD, a renowned radiation oncologist and expert in proton therapy, will assume the position of Associate Deputy Physician-in-Chief for the Memorial Sloan Kettering Regional Care Network. With this appointment, which is effective immediately, Dr. Cahlon will help oversee the network’s outpatient clinical programs, which span seven locations across New York and New Jersey.

  • Friday, November 23, 2018

Positive Data from Randomized Phase III Study Suggests That a Combination of Immunotherapy Drugs Can Help Some People with Advanced Kidney Cancer

Memorial Sloan Kettering Cancer Center (MSK) researchers presented the results of a randomized phase III trial at today’s press program for the European Society for Medical Oncology’s 2018 Congress in Munich, Germany. The results demonstrated that a combination of the immune checkpoint blocker avelumab (Bavencio®) and the tyrosine kinase inhibitor (TKI) axitinib (Inlyta®) can significantly improve progression-free survival (PFS) in people who have been previously untreated for advanced renal cell carcinoma (RCC).

  • Sunday, October 21, 2018

Whole Breast Radiation Found to Reduce Local Recurrence Following Surgery in Women with “Good Risk” DCIS

Whole breast radiation (WBRT) significantly reduced local recurrence in women with “good risk” (low risk) ductal carcinoma in situ (DCIS) following breast conservation surgery, according to researchers from Memorial Sloan Kettering Cancer Center, who presented this data in a press conference at the annual meeting of the American Society for Radiation Oncology (ASTRO).

  • Sunday, October 21, 2018

MSK Radiologist Named Winner of National Academy of Medicine's David Rall Medal

The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD, Chair of the Department of Radiology, a recipient of the David Rall Medal. The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak received the award at the 2018 NAM Annual Meeting on Monday, October 15, 2018, in Washington, D.C.

  • Monday, October 15, 2018

Samuel Bakhoum Awarded 2018 NIH Early Independence Award

Sam Bakhoum, MD, PhD, Assistant Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK), has been named a winner of the 2018 National Institutes of Health Director’s Early Independence Award, which is provided by the NIH Common Fund’s High-Risk, High-Reward Research program. This award is given to exceptional scientists who have contributed significant work in biomedical research.

  • Thursday, October 4, 2018

Memorial Sloan Kettering Announces Policy Changes

Memorial Sloan Kettering shares results of a recent review by our Boards of Overseers and Managers, as well as additional policies we are considering to enhance communication, transparency, disclosure, and oversight of outside activities and industry-supported clinical trials.

  • Saturday, September 29, 2018

Memorial Sloan Kettering and Paige.AI

MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.

  • Sunday, September 23, 2018

Memorial Sloan Kettering Cancer Center Announces Conflict of Interest Task Force

Today Memorial Sloan Kettering (MSK) announced the appointment of a task force that will assess MSK policies and processes for reporting and managing outside activities and industry-supported clinical trials.

  • Friday, September 21, 2018

Ralph Lauren Center for Cancer Care to Formally Join Memorial Sloan Kettering

The Ralph Lauren Center for Cancer Care, a Harlem-based cancer prevention and treatment program, is expected to more closely align with Memorial Sloan Kettering Cancer Center (MSK) in 2019 pending the approval of the New York State Department of Health and other state agencies. The filing deepens the longstanding partnership between MSK and the Ralph Lauren Center. 

  • Tuesday, August 7, 2018